Rheumatology

Your Article Summary

See Latest Articles

Low-dose natural human interferon- lozenges in the treatment of Behçet's syndrome
Rheumatology, 09/01/09

Kilic H et al. – Low-dose natural human IFN-alpha did not have beneficial effects on reducing the total ulcer burden among Behcet's syndrome.

• Placebo controlled, double-blind study
• 84 patients with BS with mainly skin mucosa disease and a hx of recurrent OU for 8805 1 y
• For patients with at least 2 OUs with a total diameter of ≥ mm, they were allocated to 2000 IFN-alpha IU/d, 1000 IFN-alpha IU/d, and placebo

• There were no statistically significant differences between the tx arms

Today in Autoimmune/Heritable...keeping you current

Receive free subspecialty "5-minute updates" via email

Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09

A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09

See All of Autoimmune/Heritable

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09

Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

See All of Clinical Pharmacology